选择性激动剂和对抗剂与视网膜酸受体 γ的分子相互作用
Katarzyna Powała1, Teresa Żołek1, Geoffrey Brown2
1Department of Organic and Physical Chemistry, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha, 02-097 Warsaw, Poland.
International journal of molecular sciences
|June 27, 2024
概括
全跨网红酸 (ATRA) 通过网红酸受体 (RAR) 调节基因表达. 针对特定的RAR异构体,如RARγ,显示出治疗各种疾病的希望,包括癌症和.
科学领域:
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 全转录氨酸 (ATRA) 是维生素A的代谢物,是影响细胞生长和分化的关键信号分子.
- 网红酸受体 (RARs) 通过调节基因表达来调节ATRA的作用,RARα,RARβ和RARγ异型具有不同的作用.
- 针对特定的RAR异型是开发有效的视网类药物治疗方法的关键.
研究的目的:
- 探索向视网膜酸受体玛 (RARγ) 的治疗潜力.
- 为药物设计研究调控RARγ连接体结合的分子相互作用.
- 确定开发具有改善药理动力学特性和RARγ选择性的新化合物的策略.
主要方法:
- 对RARγ激动剂和抗剂的体外和体内研究的综述.
- 分析RARγ激动剂与RARγ的联体结合域之间的分子相互作用.
- 检查基于视网类药物的药物开发中的结构-活性关系.
主要成果:
- RARα和RARγ异构体在细胞分化和干细胞维护中起着不同的作用.
- 向RARα的ATRA在治疗急性肌肉细胞白血病 (PML) 中有效.
- RARγ调制显示出治疗各种疾病的潜力,包括癌症,牛皮和.
- 了解RARγ联体结合对于设计有选择性和强效的化合物至关重要.
结论:
- 针对特定的RAR异型,特别是RARγ,提供了显著的治疗机会.
- 对RARγ分子相互作用的进一步研究将有助于开发用于各种疾病的新药.
- 在保持同型特异性的同时优化化合物特性对于成功的药物开发至关重要.
更多相关视频
05:03Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling
Published on: December 27, 2024
1.1K
09:07Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
8.2K
相关概念视频
01:25Drug-Receptor Interaction: Agonist
2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K
01:29Drug-Receptor Interactions
5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
01:29The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
01:28Drug-Receptor Interaction: Antagonist
2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.8K
01:30Combined Effects of Drugs: Antagonism
8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K